Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2021

      With strong growth in operating results - Revenues up 380% (compared to corresponding period in 2020)


      News provided by

      Ellomay Capital Ltd.

      Dec 26, 2021, 01:30 ET

      Share this article

      Share this article


      TEL AVIV, Israel, Dec. 26, 2021 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported unaudited financial results for the three and nine month periods ended September 30, 2021.

      Financial Highlights

      • Revenues were approximately €32.8 million for the nine months ended September 30, 2021, compared to approximately €6.8 million for the nine months ended September 30, 2020. The revenue increase is mainly attributable to the achievement of PAC (preliminary acceptance certificate) of the photovoltaic plant held by Talasol Solar S.L. (the "Talasol PV Plant" and "Talasol", respectively) on January 27, 2021, upon which the Company commenced recognition of revenues. The increase is also attributable to the Groen Gas Gelderland B.V. biogas facility (the "Gelderland Biogas Plant") acquisition, in December 2020 and to improved operational efficiency at the Company's biogas plants in the Netherlands.
      • Operating expenses were approximately €11.7 million for the nine months ended September 30, 2021, compared to approximately €3.4 million for the nine months ended September 30, 2020. This increase is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020. Depreciation expenses were approximately €11 million for the nine months ended September 30, 2021, compared to approximately €2.2 million for the nine months ended September 30, 2020.
      • Project development costs were approximately €1.8 million for the nine months ended September 30, 2021, compared to approximately €3 million for the nine months ended September 30, 2020. This decrease is mainly due to capitalization of expenses in connection with the project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel (the "Manara PSP").
      • General and administrative expenses were approximately €3.9 million for the nine months ended September 30, 2021, compared to approximately €3.3 million for the nine months ended September 30, 2020. The increase is mostly due to increased D&O liability insurance costs and to Talasol's expenses following the achievement of PAC of the Talasol PV Plant on January 27, 2021.
      • The Company's share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €0.3 million for the nine months ended September 30, 2021, compared to approximately €1.9 million for the nine months ended September 30, 2020. This decrease is mainly attributable to the decrease in revenues of Dorad Energy Ltd. ("Dorad") and higher financing expenses incurred by Dorad for the period as a result of the CPI indexation of loans from banks.
      • Financing expenses, net were approximately €10.4 million for the nine months ended September 30, 2021, compared to approximately €2.3 million for the nine months ended September 30, 2020. The increase in financing expenses, net, was mainly due to:
        - a)  financing expenses in connection with the Talasol PV Plant previously capitalized to fixed assets that are recognized in profit and loss starting from PAC, consisting of (i) approximately €1.5 million of interest on bank loans, (ii) approximately €0.9 million of swap related payments, (iii) approximately €1.4 million of expenses in connection with Talasol's project finance, and (iv) approximately €1.5 million of interest accrued on shareholder loans granted by the minority shareholders of Talasol;
        - b)  approximately €0.8 million of expenses for the early repayment of the Company's Series B Debentures; and
        - c)  expenses recorded in connection with the reevaluation of the Company's derivative transactions and of a loan provided to U. Dori Energy Infrastructures Ltd. in the aggregate amount of approximately €0.4 million during the nine months ended September 30, 2021, compared to an aggregate income of approximately €1.5 million during the nine months ended September 30, 2020.
      • Taxes on income were approximately €0.6 million for the nine months ended September 30, 2021 compared to approximately €0.2 million for the nine months ended September 30, 2020. The increase in taxes on income mainly results from the achievement of PAC of the Talasol PV Plant on January 27, 2021.
      • Net loss was approximately €6.4 million for the nine months ended September 30, 2021, compared to approximately €5.7 million for the nine months ended September 30, 2020.
      • Total other comprehensive loss was approximately €8.9 million for the nine months ended September 30, 2021, compared to a profit of approximately €3.1 million for the nine months ended September 30, 2020. The change was mainly due to changes in fair value of cash flow hedges and from foreign currency translation differences on NIS denominated operations, as a result of fluctuations in the euro/NIS exchange rates.
      • Total comprehensive loss was approximately €15.4 million for the nine months ended September 30, 2021, compared to approximately €2.6 million for the nine months ended September 30, 2020.
      • EBITDA was approximately €15.6 million for the nine months ended September 30, 2021, compared to a negative EBITDA of approximately €(1) million for the nine months ended September 30, 2020.
      • Net cash from operating activities was approximately €12.9 million for the nine months ended September 30, 2021, compared to net cash used in operating activities of approximately €2.3 million for the nine months ended September 30, 2020. The increase in net cash from operating activities is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021, upon which the Company commenced recognition of revenues and expenses.
      • As of December 1, 2021, the Company held approximately €59.2 million in cash and cash equivalents, €28 million in short term deposits and approximately €6.5 million in restricted short-term and long-term cash.
      • In December 2021, Talasol entered into a Facilities Agreement with European institutional lenders (the "Facilities Agreement"). The Facilities Agreement provides for the provision of a term loan facility in two tranches: (i) a term loan in the amount of €155 million for 22.5 years, and (ii) a term loan in the amount of €20 million for 21 years (together, the "New Financing"). The aggregate New Financing amount (€175 million), will be used by Talasol to repay the current outstanding project finance debt of Talasol in the amount of €121 million (the "Current Financing"). The weighted average life of the New Financing is approximately 11.5 years, compared to an original weighted average life of 5.5 years of the Current Financing. The New Financing bears a fixed annual interest rate at a weighted average of approximately 3%, compared to a variable interest rate that was fixed at an average of approximately 3% by an interest rate swap contract in the Current Financing. Out of the New Financing amount, €6.9 million will be deposited in Talasol's account as a debt service fund and €10 million will be deposited in Talasol's bank account as security for a letter of credit to the PPA provider (the "PPA Security Fund"). The PPA Security Fund will be reduced by €1 million every year, up to a minimum amount of €3.5 million, which will be released at the expiration of the PPA. The financial closing of the New Financing is expected to occur in the coming weeks.
      • In October 2021, the Company issued NIS 120 million par value of its unsecured non-convertible Series C Debentures (the "Additional Series C Debentures") to Israeli classified investors in a private placement (the "Private Placement") for an aggregate gross consideration of approximately NIS 121.6 million, reflecting a price of NIS 1.0135 per NIS 1 principal amount. Following completion of the private placement, the aggregate outstanding par value of the Company's Series C Debentures is approximately NIS 414.6 million. The Additional Series C Debentures have identical terms to the existing Series C Debentures of the Company.

      Third Quarter 2021 CEO Review

      Ran Fridrich, CEO and a board member of the Company, provided the following CEO review:

      The results for the third quarter and of the nine months ended September 30, 2021 present a continuous improvement in revenues, gross profit and operating profit while maintaining a strong cash flow from operations and are in line with the Company's business plan. The third quarter was characterized by higher electricity prices in Europe, which had a positive effect on the Company's revenues from the sale of electricity in Spain. The higher electricity prices resulted in an increase in Talasol's revenues that were derived from the production that is not subject to the financial power swap (approximately 25% of the actual output of the Talasol PV plant) and in the revenues derived by the Company's Spanish 7.9MW photovoltaic portfolio.

      The Adjusted EBITDA for the nine months ended September 30, 2021 was approximately €21 million and the Adjusted FFO for the nine months ended September 30, 2021 was approximately €14 million.

      Alongside these improvements, the reevaluation during the third quarter of the financial power swap executed in connection with the Talasol PV plant was negative and amounted to approximately €11.9 million, due to the substantial outstanding amount of the derivative (notional value of approximately €130 million). Such negative reevaluation is recorded as part of the other comprehensive income (loss) and does not otherwise impact the Company's profit and loss statement.

      Subsequent to the balance sheet date, Talasol successfully entered into the Facilities Agreement to refinance the Talasol project. The new financing doubles the weighted average life of the debt without any increase in interest rate, while increasing the coverage ratio from 1.3 to 1.7.

      Following the anticipated closing of the Facilities Agreement, Talasol expects to distribute an aggregate amount of approximately €30 million to its shareholders, including the Company, which holds 51% of Talasol. In addition, Talasol's free cash will increase by approximately €3 million per year for the upcoming 9 years, thus increasing future distributions.

      The Company is currently engaged in the construction of 2 main projects – 

      • A 28 MW photovoltaic project in Spain - The construction is in advanced stages and connection to the electricity grid is expected in February 2022; and
      • A 156 MW pumped storage project in the Menara cliff, Israel - the works are progressing as planned, the construction of the access tunnel is in progress and the construction of the reservoirs and the low pressure tunnel will begin in the upcoming weeks, all in accordance with the planned schedules.

      The development of photovoltaic projects that are in advanced stages in Italy (approximately 480 MW) is also progressing as planned. The initial 20 MW are expected to enter into EPC agreements and issue limited notices to proceed in the upcoming days. An additional 100 MW are expected to receive final required permits shortly and construction is expected to commence in the second half of 2022. Additional photovoltaic projects are being developed in Spain (150 MW) and in Israel (photovoltaic + storage).

      The Company's three main focal points are: improving the results of its operating projects, managing the construction of projects under construction, and developing the backlog of projects that will be constructed in the coming years.

      Use of NON-IFRS Financial Measures

      EBITDA, Adjusted EBITDA and Adjusted FFO are non-IFRS measures. EBITDA is defined as earnings before financial expenses, net, taxes, depreciation and amortization and Adjusted FFO is calculated by deducting tax expenses and interest expenses on bank loans, debentures and others from the Adjusted EBITDA. The Company uses the terms "Adjusted EBITDA" and "Adjusted FFO" to highlight the fact that in the calculation of these Non-IFRS financial measures the Company presents the revenues from the Talmei Yosef PV Plant under the fixed asset model and not under IFRIC 12, presents its share in Dorad based on distributions of profit and not on the basis of equity gain using the equity method and includes the financial results of Talasol for the period prior to achievement of PAC that were not recognized in the profit and loss statement based on accounting rules. The Company presents these measures in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers these non-IFRS measures to be important measures of comparative operating performance, these non-IFRS measures should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. These non-IFRS measures do not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, are not necessarily indicative of amounts that may be available for discretionary uses. In addition, Adjusted FFO does not represent and is not an alternative to cash flow from operations as defined by IFRS and is not an indication of cash available to fund all cash flow needs, including the ability to make distributions. Not all companies calculate EBITDA, Adjusted EBITDA or Adjusted FFO in the same manner, and the measures as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA, Adjusted EBITDA and Adjusted FFO may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses these measures internally as performance measures and believes that when these measures are combined with IFRS measures they add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 14 of this press release.

      About Ellomay Capital Ltd.

      Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

      To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

      • Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9MW in Israel;
      • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;
      • 51% of Talasol, which owns a photovoltaic plant with installed capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
      • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;
      • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.

      For more information about Ellomay, visit http://www.ellomay.com.

      Information Relating to Forward-Looking Statements

      This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and delays, technical and other disruptions in the operations or construction of the power plants owned by the Company or in the development efforts of the projects under development by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

      Contact:

      Kalia Rubenbach (Weintraub)
      CFO
      Tel: +972 (3) 797-1111
      Email: [email protected]

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Statements of Financial Position

         

      September 30,

      December 31,

      September 30,

         

      2021

      2020

      2021

         

      (Unaudited)

      (Audited)

      (Unaudited)

             

      Convenience Translation

         

      € in thousands

      into US$ in thousands*

      Assets

             

      Current assets

             

      Cash and cash equivalents

       

      58,053

      66,845

      67,168

      Marketable securities

       

      -

      1,761

      -

      Short term deposits

       

      -

      8,113

      -

      Restricted cash

       

      4,216

      -

      4,878

      Receivable from concession project

       

      1,674

      1,491

      1,937

      Trade and other receivables

       

      11,146

      9,825

      12,896

         

      75,089

      88,035

      86,879

      Non-current assets

             

      Investment in equity accounted investee

       

      32,267

      32,234

      37,333

      Advances on account of investments

       

      1,561

      2,423

      1,806

      Receivable from concession project

       

      25,560

      25,036

      29,573

      Fixed assets

       

      325,564

      264,095

      376,682

      Right-of-use asset

       

      23,152

      17,209

      26,787

      Intangible asset

       

      4,580

      4,604

      5,299

      Restricted cash and deposits

       

      6,247

      9,931

      7,228

      Deferred tax

       

      8,264

      3,605

      9,562

      Long term receivables

       

      1,155

      2,762

      1,336

      Derivatives

       

      1,557

      10,238

      1,801

         

      429,907

      372,137

      497,407

      Total assets

       

      504,996

      460,172

      584,286

      Liabilities and Equity

             

      Current liabilities

             

      Current maturities of long term bank loans

       

      12,447

      10,232

      14,401

      Current maturities of long term loans

       

      3,549

      4,021

      4,106

      Debentures

       

      13,296

      10,600

      15,384

      Trade payables

       

      3,939

      12,387

      4,557

      Other payables

       

      14,799

      **6,044

      17,123

      Derivatives short term

       

      5,983

      **1,378

      6,922

      Lease liability short term

       

      4,874

      **490

      5,639

         

      58,887

      45,152

      68,132

      Non-current liabilities

             

      Lease liability

       

      15,602

      17,299

      18,052

      Liabilities to banks

       

      144,506

      134,520

      167,196

      Other long term loans

       

      52,702

      49,396

      60,977

      Debentures

       

      83,787

      72,124

      96,943

      Deferred tax

       

      8,375

      7,806

      9,690

      Other long term liabilities

       

      6,178

      513

      7,148

      Derivatives

       

      12,764

      8,336

      14,768

         

      323,914

      289,994

      374,774

      Total liabilities

       

      382,801

      335,146

      442,906

               

      Equity

             

      Share capital

       

      25,578

      25,102

      29,594

      Share premium

       

      85,774

      82,401

      99,242

      Treasury shares

       

      (1,736)

      (1,736)

      (2,009)

      Transaction reserve with non-controlling Interests

       

      5,145

      6,106

      5,953

      Reserves

       

      2,028

      4,164

      2,346

      Retained earnings

       

      1,130

      8,191

      1,307

      Total equity attributed to shareholders of the Company

       

      117,919

      124,228

      136,433

      Non-Controlling Interest

       

      4,276

      798

      4,947

      Total equity

       

      122,195

      125,026

      141,380

      Total liabilities and equity

       

      504,996

      460,172

      584,286

       

      * Convenience translation into US$ (exchange rate as at September 30, 2021: EUR 1 = US$ 1.16)

      ** Reclassified

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Statements of Comprehensive Income (Loss) (in thousands, except per share data)

       

       
       

      For the three
      months ended
      September 30,

      For the nine
      months ended
      September 30,

      For the year
      ended
      December 31,

      For the nine
      months ended
      September 30,

       

      2021

      2020

      2021

      2020

      2020

      2021

       

      Unaudited

      Unaudited

      Audited

      Unaudited

       

       

       

      € in thousands

      Convenience Translation into US$*

      Revenues

      13,311

      2,630

      32,766

      6,844

      9,645

      37,911

      Operating expenses

      (4,144)

      (1,264)

      (11,650)

      (3,410)

      (4,951)

      (13,479)

      Depreciation and amortization expenses

      (3,992)

      (797)

      (11,048)

      (2,244)

      (2,975)

      (12,783)

      Gross profit

      5,175

      569

      10,068

      1,190

      1,719

      11,649

                   

      Project development costs

      (726)

      (674)

      (1,845)

      (3,012)

      (3,491)

      (2,135)

      General and administrative expenses

      (1,377)

      (1,122)

      (3,949)

      (3,326)

      (4,512)

      (4,569)

      Share of profits of equity accounted investee

      1,056

      1,055

      284

      1,905

      1,525

      329

      Other income

      -

      -

      -

      -

      2,100

      -

      Operating profit (loss)

      4,128

      (172)

      4,558

      (3,243)

      (2,659)

      5,274

                   

      Financing income

      630

      550

      2,346

      1,340

      2,134

      2,714

      Financing income (expenses) in connection with derivatives and warrants, net

      (462)

      433

      (403)

      1,532

      1,094

      (466)

      Financing expenses in connection with projects finance

      (1,870)

      (524)

      (5,528)

      (1,368)

      (1,863)

      (6,396)

      Financing expenses  in connection with debentures

      (532)

      (438)

      (2,800)

      (1,390)

      (2,155)

      (3,240)

      Interest expenses on minority shareholder loan

      (565)

      -

      (1,504)

      -

      -

      (1,740)

      Other financing expenses

      (2,165)

      (1,202)

      (2,549)

      (2,404)

      (2,844)

      (2,949)

      Financing expenses, net

      (4,964)

      (1,181)

      (10,438)

      (2,290)

      (3,634)

      (12,077)

      Loss before taxes on income

      (836)

      (1,353)

      (5,880)

      (5,533)

      (6,293)

      (6,803)

      Tax benefit (Taxes on income)

      (459)

      (72)

      (552)

      (160)

      125

      (639)

      Loss for the period

      (1,295)

      (1,425)

      (6,432)

      (5,693)

      (6,168)

      (7,442)

      Loss attributable to:

                 

      Owners of the Company

      (2,147)

      (940)

      (7,061)

      (4,411)

      (4,627)

      (8,170)

      Non-controlling interests

      852

      (485)

      629

      (1,282)

      (1,541)

      728

      Loss for the period

      (1,295)

      (1,425)

      (6,432)

      (5,693)

      (6,168)

      (7,442)

      Other comprehensive income (loss) items that

                 

      after initial recognition in comprehensive  income

                 

       (loss) were or will be transferred to profit or loss:

                 

      Foreign currency translation differences for foreign operations

      3,904

      (1,197)

      5,588

      (1,283)

      (482)

      6,465

      Effective portion of change in fair value of cash flow hedges

      (7,444)

      12,942

      (12,646)

      3,653

      2,210

      (14,632)

      Net change in fair value of cash flow hedges

      transferred to profit or loss

      (647)

      528

      (1,872)

      718

      555

      (2,166)

      Total other comprehensive income (loss)

      (4,187)

      12,273

      (8,930)

      3,088

      2,283

      (10,333)

                   

      Total other comprehensive income (loss) attributable to:

                 

      Owners of the Company

      (372)

      5,531

      (2,136)

      794

      881

      (2,472)

      Non-controlling interests

      (3,815)

      6,742

      (6,794)

      2,294

      1,402

      (7,861)

      Total other comprehensive income (loss)

      (4,187)

      12,273

      (8,930)

      3,088

      2,283

      (10,333)

                   

      Total comprehensive income (loss) for the period

      (5,482)

      10,848

      (15,362)

      (2,605)

      (3,885)

      (17,775)

                   

      Total comprehensive income (loss) for the period attributable to:

                 

      Owners of the Company

      (2,519)

      4,591

      (9,197)

      (3,617)

      (3,746)

      (10,642)

      Non-controlling interests

      (2,963)

      6,257

      (6,165)

      1,012

      (139)

      (7,133)

      Total comprehensive income (loss) for the period

      (5,482)

      10,848

      (15,362)

      (2,605)

      (3,885)

      (17,775)

                   

      Basic net loss per share

      (0.17)

      (0.07)

      (0.55)

      (0.36)

      (0.38)

      (0.64)

      Diluted net loss per share

      (0.17)

      (0.07)

      (0.55)

      (0.36)

      (0.38)

      (0.64)

      * Convenience translation into US$ (exchange rate as at September 30, 2021: EUR 1 = US$ 1.16)

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (in thousands)

       
           

      Attributable to shareholders of the Company

      Non- controlling

      Total

           

      Interests

      Equity

       

       

       

       

      Share capital

       

       

       

      Share
      premium

       

       

       

      Retained
      earnings

       

       

       

      Treasury
      shares

       

      Translation
      reserve from
      foreign
      operations

       

       

       

      Hedging
      Reserve

      Interests
      Transaction
      reserve with
      non-controlling
      Interests

       

       

       

      Total

         
       

      € in thousands

      For the nine months ended September 30, 2021
      (unaudited):

                         

      Balance as at January 1, 2021

      25,102

      82,401

      8,191

      (1,736)

      3,823

      341

      6,106

      124,228

      798

      125,026

      Loss for the period

      -

      -

      (7,061)

      -

      -

      -

      -

      (7,061)

      629

      (6,432)

      Other comprehensive loss for the period

      -

      -

      -

      -

      5,270

      (7,406)

      -

      (2,136)

      (6,794)

      (8,930)

      Total comprehensive loss for the period

      -

      -

      (7,061)

      -

      5,270

      (7,406)

      -

      (9,197)

      (6,165)

      (15,362)

      Transactions with owners of the Company, recognized
      directly in equity:

                         

      Issuance of Capital note to non-controlling interest

      -

      -

      -

      -

      -

      -

      -

      -

      8,682

      8,682

      Acquisition of shares in subsidiaries from non-controlling interests

      -

      -

      -

      -

      -

      -

      (961)

      (961)

      961

      -

      Warrants exercise

      454

      3,348

      -

      -

      -

      -

      -

      3,802

      -

      3,802

      Options exercise

      22

      -

      -

      -

      -

      -

      -

      22

      -

      22

      Share-based payments

      -

      25

      -

      -

      -

      -

      -

      25

      -

      25

       Balance as at September 30, 2021

      25,578

      85,774

      1,130

      (1,736)

      9,093

      (7,065)

      5,145

      117,919

      4,276

      122,195

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)

       
           

      Attributable to shareholders of the Company

      Non-
      controlling

      Total

           

      Interests

      Equity

       

       

       

       

      Share
      capital

       

       

       

      Share premium

       

       

       

      Retained
      earnings

       

       

       

      Treasury
      shares

       

      Translation
      reserve from
      foreign
      operations

       

       

       

      Hedging
      Reserve

      Interests
      Transaction
      reserve with
      non-controlling
      Interests

       

       

       

      Total

         
       

      € in thousands

      For the three months ended September 30, 2021
      (unaudited):

                         

      Balance as at July 1, 2021

      25,578

      85,762

       *3,277

      (1,736)

      5,459

      (3,059)

      5,145

      120,426

      7,239

      127,665

      Loss for the period

      -

      -

      (2,147)

      -

      -

      -

      -

      (2,147)

      852

      (1,295)

      Other comprehensive loss for the period

      -

      -

      -

      -

      3,634

      (4,006)

      -

      (372)

      (3,815)

      (4,187)

      Total comprehensive loss for the period

      -

      -

      (2,147)

      -

      3,634

      (4,006)

      -

      (2,519)

      (2,963)

      (5,482)

      Transactions with owners of the Company, recognized
      directly in equity:

                         

      Share-based payments

      -

      12

      -

      -

      -

      -

      -

      12

      -

      12

       Balance as at September 30, 2021

      25,578

      85,774

      1,130

      (1,736)

      9,093

      (7,065)

      5,145

      117,919

      4,276

      122,195

      * Reclassified - The Company capitalized financing expenses related to the equity investment amount provided in connection with Manara PSP in order to reflect more appropriately the nature and the way in which economic benefits are expected to be derived from the use of such costs.

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Statements of Changes in Equity (in thousands) (cont'd)

                           
                       

      Non-

       
                       

      controlling

      Total

       

      Attributable to shareholders of the Company

      Interests

      Equity

           

      Retained

       

      Translation

       

      Transaction

           
           

      earnings

       

      reserve from

       

      reserve with

           
       

      Share

      Share

      (accumulated

      Treasury

      foreign

      Hedging

      non-controlling

           
       

      Capital

      Premium

      deficit)

      shares

      operations

      Reserve

      Interests

      Total

         
         

      € in thousands

      For the nine months ended September 30, 2020:

                         

      Balance as at January 1, 2020

      21,998

      64,160

      12,818

      (1,736)

      4,356

      (1,073)

      6,106

      106,629

      937

      107,566

      Loss for the period

      -

      -

      (4,411)

      -

      -

      -

      -

      (4,411)

      (1,282)

      (5,693)

      Other comprehensive loss for the period

      -

      -

      -

      -

      (1,393)

      2,187

      -

      794

      2,294

      3,088

      Total comprehensive loss for the period

      -

      -

      (4,411)

      -

      (1,393)

      2,187

      -

      (3,617)

      1,012

      (2,605)

      Transactions with owners of the Company,
      recognized directly in equity:

                         

      Options exercise

      20

      -

      -

      -

      -

      -

      -

      20

      -

      20

      Share-based payments

      -

      28

      -

      -

      -

      -

      -

      28

      -

      28

      Issuance of ordinary shares

      3,084

      18,191

      -

      -

      -

      -

      -

      21,275

      -

      21,275

      Balance as at September 30, 2020

      25,102

      82,379

      8,407

      (1,736)

      2,963

      1,114

      6,106

      124,335

      1,949

      126,284

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)

             
         

      Non-

       
         

      controlling

      Total

       

      Attributable to shareholders of the Company

      Interests

      Equity

                           
               

      Translation

       

      Transaction

           
       

       

      Share

       

      Share

       

      Retained

       

      Treasury

      Reserve from

      foreign

       

      Hedging

      reserve with

      non-controlling

           
       

      capital

      premium

      earnings

      shares

      operations

      Reserve

      Interests

      Total

         
       

      € in thousands

      For the year ended  December 31, 2020 (audited):

                         

      Balance as at January 1, 2020

      21,998

      64,160

      12,818

      (1,736)

      4,356

      (1,073)

      6,106

      106,629

      937

      107,566

      Profit (loss) for the year

      -

      -

      (4,627)

      -

      -

      -

      -

      (4,627)

      (1,541)

      (6,168)

      Other comprehensive loss for the year

      -

      -

      -

      -

      (533)

      1,414

      -

      881

      1,402

      2,283

      Total comprehensive loss for the year

      -

      -

      (4,627)

      -

      (533)

      1,414

      -

      (3,746)

      (139)

      (3,885)

      Transactions with owners of the Company, 
      recognized directly in equity:

                         

      Issuance of ordinary shares

      3,084

      18,191

      -

      -

      -

      -

      -

      21,275

      -

      21,275

      Options exercise

      20

      -

      -

      -

      -

      -

      -

      20

      -

      20

      Share-based payments

      -

      50

      -

      -

      -

      -

      -

      50

      -

      50

      Balance as at

                         

       December 31, 2020

      25,102

      82,401

      8,191

      (1,736)

      3,823

      341

      6,106

      124,228

      798

      125,026

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)

           

      Attributable to shareholders of the Company

      Non-
      controlling

      Total

      Interests

      Equity

       

      Share
      capital

      Share
      premium

      Retained
      earnings

      Treasury
      shares

      Translation
      reserve from
      foreign
      operations

      Hedging
      Reserve

      Interests
      Transaction
      reserve with
      non-controlling
      Interests

      Total

         
       

      Convenience translation into US$*

      For the nine months ended September 30, 2021
      (unaudited):

                         

      Balance as at January 1, 2021

      29,044

      95,339

      9,477

      (2,009)

      4,423

      395

      7,065

      143,734

      923

      144,657

      Loss for the period

      -

      -

      (8,170)

      -

      -

      -

      -

      (8,170)

      728

      (7,442)

      Other comprehensive loss for the period

      -

      -

      -

      -

      6,097

      (8,569)

      -

      (2,472)

      (7,861)

      (10,333)

      Total comprehensive loss for the period

      -

      -

      (8,170)

      -

      6,097

      (8,569)

      -

      (10,642)

      (7,133)

      (17,775)

      Transactions with owners of the Company, recognized
      directly in equity:

                         

      Issuance of Capital note to non-controlling interest

      -

      -

      -

      -

      -

      -

      -

      -

      10,045

      10,045

      Buy of shares in subsidiaries from non-controlling
      interests

      -

      -

      -

      -

      -

      -

      (1,112)

      (1,112)

      1,112

      -

      Warrants exercise

      525

      3,874

      -

      -

      -

      -

      -

      4399

      -

      4,399

      Options exercise

      25

      -

      -

      -

      -

      -

      -

      25

      -

      25

      Share-based payments

      -

      29

      -

      -

      -

      -

      -

      29

      -

      29

       Balance as at September 30, 2021

      29,594

      99,242

      1,307

      (2,009)

      10,520

      (8,174)

      5,953

      136,433

      4,947

      141,380

      * Convenience translation into US$ (exchange rate as at September 30, 2021: EUR 1 = US$ 1.16)

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Unaudited Interim Statements of Cash Flows

               
       

      For the three months
      ended September 30
      ,

      For the nine months
      ended September 30
      ,

      For the year
      ended
      December 31,

      For the nine
      months ended
      September 30,

       

      2021

      2020

      2021

      2020

      2020

      2021

       

      Unaudited

      Unaudited

      Audited

      Unaudited

       

      € in thousands

      Convenience
      Translation into
      US$*

      Cash flows from operating activities

                 

      Loss for the period

      (1,295)

      (1,425)

      (6,432)

      (5,693)

      (6,168)

      (7,442)

      Adjustments for:

                 

      Financing expenses, net

      4,964

      1,181

      10,438

      2,290

      3,634

      12,077

      Depreciation and amortization

      3,992

      797

      11,048

      2,244

      2,975

      12,783

      Share-based payment transactions

      12

      8

      25

      28

      50

      29

      Share of profits of equity accounted investee

      (1,056)

      (1,055)

      (284)

      (1,905)

      (1,525)

      (329)

      Payment of interest on loan from an equity accounted investee

      -

      -

      859

      582

      582

      994

      Change in trade receivables and other receivables

      (4,301)

      (858)

      (6,425)

      (731)

      (3,868)

      (7,434)

      Change in other assets

      582

      618

      (200)

      384

      179

      (231)

      Change in receivables from concessions project

      556

      519

      1,313

      1,223

      1,426

      1,519

      Change in trade payables

      928

      (304)

      (13)

      (339)

      190

      (15)

      Change in other payables

      3,499

      469

      6,807

      837

      (1,226)

      7,876

      Income tax expense (tax benefit)

      459

      72

      552

      160

      (125)

      639

      Income taxes paid

      -

      (88)

      (15)

      (88)

      (119)

      (17)

      Interest received

      406

      445

      1,327

      1,314

      2,075

      1,535

      Interest paid

      (2,243)

      (728)

      (6,100)

      (2,581)

      (3,906)

      (7,058)

      Net cash from (used in) operating activities

      6,503

      (349)

      12,900

      (2,275)

      (5,826)

      14,926

      Cash flows from investing activities

                 

      Acquisition of fixed assets

      (8,785)

      (22,398)

      (72,578)

      (103,678)

      (128,420)

      (83,974)

      Acquisition of subsidiary, net of cash acquired

      -

      -

      -

      -

      (7,464)

      -

      VAT associated with the acquisition of fixed assets

      2,310

      -

      2,310

      -

      -

      2,673

      Repayment of loan by an equity accounted investee

      -

      -

      1,400

      1,923

      1,978

      1,620

      Loan to an equity accounted investee

      (52)

      -

      (296)

      -

      (181)

      (342)

      Advances on account of investments

      -

      (1,554)

      (8)

      (1,554)

      (1,554)

      (9)

      Settlement of derivatives contract

      -

      -

      (252)

      -

      -

      (292)

      Proceeds (investment) in restricted cash, net

      (19)

      (230)

      (204)

      22,350

      23,092

      (236)

      Proceeds (investment) in short term deposit

      -

      (1,407)

      8,533

      (1,407)

      (1,323)

      9,873

      Proceeds from marketable securities

      -

      1,364

      1,785

      1,364

      1,800

      2,065

      Acquisition of marketable securities

      -

      -

      -

      -

      (1,481)

      -

      Compensation as per agreement with Erez Electricity Ltd

      -

      -

      -

      1,418

      1,418

      -

      Net cash used in investing activities

      (6,546)

      (24,225)

      (59,310)

      (79,584)

      (112,135)

      (68,622)

      Cash flows from financing activities

                 

      Sale of shares in subsidiaries to non-controlling interests

      -

      -

      1,400

       

      -

      1,620

      Proceeds from options

      -

      20

      22

      20

      20

      25

      Cost associated with long term loans

      (1,122)

      -

      (1,319)

      -

      (734)

      (1,526)

      Proceeds from long term loans

      39

      21,291

      32,515

      101,837

      111,357

      37,620

      Repayment of long-term loans

      (7,360)

      -

      (10,750)

      (2,766)

      (3,959)

      (12,438)

      Repayment of Debentures

      -

      -

      (30,730)

      (26,923)

      (26,923)

      (35,555)

      Issuance / exercise of warrants

      -

       

      3,675

      320

      2,544

      4,252

      Issuance of ordinary shares

      -

      8,087

      -

      21,275

      21,275

      -

      Repayment of Lease liability

      (4,086)

      -

      (4,086)

      -

      -

      (4,728)

      Proceeds from issue of convertible debentures

      -

      -

      15,571

      -

      -

      18,016

      Proceeds from issuance of Debentures, net

      -

      -

      25,465

      -

      38,057

      29,463

      Net cash from (used in) financing activities

      (12,529)

      29,398

      31,763

      93,763

      141,637

      36,749

                   

      Effect of exchange rate fluctuations on cash and cash
      equivalents

      3,366

      (2,067)

      5,855

      (2,424)

      (1,340)

      6,774

      Increase (decrease) in cash and cash equivalents

      (9,206)

      2,757

      (8,792)

      9,480

      22,336

      (10,173)

      Cash and cash equivalents at the beginning of the period

      67,259

      51,232

      66,845

      44,509

      44,509

      77,341

      Cash and cash equivalents at the end of the period

      58,053

      53,989

      58,053

      53,989

      66,845

      67,168

      * Convenience translation into US$ (exchange rate as at September 30, 2021: EUR 1 = US$ 1.16)

      Ellomay Capital Ltd. and its Subsidiaries

      Operating Segments

                     
       

      PV

           

      Total

         
       

      Italy

      Spain

      Ellomay
      Solar1

        Talasol

       

      Israel2

      Bio

      Gas

       

      Dorad

      Manara

      PSP

      reportable

      segments

       

      Reconciliations

       

      Consolidated

       

      For the nine months ended September 30, 2021

       

      Unaudited

       

      € in thousands

                             

      Revenues

      -

      2,194

      -

      20,3303

      3,339

      9,417

      38,625

      -

      73,905

      (41,139)

      32,766

      Operating expenses

      -

      (738)

      -

      (3,004)

      (272)

      (7,636)

      (29,199)

      -

      (40,849)

      29,199

      (11,650)

      Depreciation expenses

      -

      (678)

      -

      (7,673)

      (1,745)

      (2,337)

      (4,070)

      -

      (16,503)

      5,455

      (11,048)

      Gross profit (loss)

      -

      778

      -

      9,653

      1,322

      (556)

      5,356

      -

      16,553

      (6,485)

      10,068

      Project development
      costs

                         

      (1,845)

      General and

                           

       administrative expenses

                         

      (3,949)

      Share of loss of equity

                           

      accounted investee

                         

      284

      Operating profit

                         

      4,558

      Financing income

                         

      2,346

      Financing expenses in connection

                           

       with derivatives and warrants, net

                         

      (403)

      Financing expenses, net

                         

      (12,381)

      Loss before taxes

                           

       on Income

                         

      (5,880)

      Segment assets as at

                           

       September 30, 2021

      1,091

      14,795

      7,849

      241,161

      37,355

      34,616

      115,187

      97,487

      549,541

      (44,544)

      504,997

      1 Ellomay Solar, S.L, the developer of a 28 MW solar project near the Talasol PV Plant.
      2 The Talmei Yosef PV Plant located in Israel is presented under the fixed asset model and not under the financial asset model as per IFRIC 12.
      3 Not including an amount of approximately €1 million of proceeds from the sale of electricity prior to January 27, 2021 (the date in which the Talasol PV Plant achieved PAC).

      Ellomay Capital Ltd. and its Subsidiaries

      Reconciliation of Loss to EBITDA (in thousands)

               
       

      For the three months
      ended September 30,

      For the nine
      months ended
      September 30,

      For the year
      ended December
      31,

      For the nine
      months ended
      September 30,

       

      2021

      2020

      2021

      2020

      2020

      2021

       

      Unaudited

       

      € in thousands

      Convenience
      Translation into
      US$*

      Loss for the period

      (1,295)

      (1,425)

      (6,432)

      (5,693)

      (6,168)

      (7,442)

      Financing expenses, net

      4,964

      1,181

      10,438

      2,290

      3,634

      12,077

      Taxes on income

      459

      72

      552

      160

      (125)

      639

      Depreciation

      3,992

      797

      11,048

      2,244

      2,975

      12,783

      EBITDA

      8,120

      625

      15,606

      (999)

      316

      18,057

      * Convenience translation into US$ (exchange rate as at September 30, 2021: EUR 1 = US$ 1.16)

      Reconciliation of Loss to Adjusted EBITDA and to Adjusted FFO

       
       

      For the nine months ended
      September 30, 2021

       

      Unaudited

       

      € in thousands

      Loss for the period

      (6,432)

      Financing expenses, net

      10,438

      Taxes on income

      552

      Depreciation

      11,048

      Adjustment to the Share of loss of equity accounted investee to
      include the Company's share in distributions 

      1,975

      Adjustment to the revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      2,514

      Adjustment to include the financial revenues of the Talasol for the
      period prior to achievement of PAC that were not recognized in the
      profit and loss statement based on accounting rules

      895

      Adjusted EBITDA

      20,990

      Taxes on income

      (552)

      Interest and SWAP expenses on bank loans and debentures

      (6,409)

      Adjusted FFO

      14,029

      Information for the Company's Debenture Holders

      Pursuant to the Deeds of Trust governing the Company's Series C and Series D Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2021 and below.

      Net Financial Debt

      As of September 30, 2021, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €41.4 million (consisting of approximately €231.54 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €99.55 million in connection with the Series C Debentures issuances (in July 2019,  October 2020 and February 2021) and Series D Debentures issuance (in February 2021), net of approximately €58.1 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €231.56 million of project finance and related hedging transactions of the Company's subsidiaries).

      4 Short-term and long-term debt from banks and other interest bearing financial obligations amount provided above, includes an amount of approximately €11.4 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet. 

      5 Debentures amount provided above, includes an amount of approximately €2.4 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet. 

      6 The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).

      Information for the Company's Series C Debenture Holders.

      The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of September 30, 2021, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was approximately €122.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) was 25.3%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA7, was 2.1.

      The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended September 30, 2021:

       

      For the four quarter period
      ended September 30, 2021

       

      Unaudited

       

      € in thousands

      Loss for the period

      (6,907)

      Financing expenses, net

      11,782

      Taxes on income

      267

      Depreciation

      11,779

      Adjustment to revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      3,112

      Share-based payments

      47

      Adjusted EBITDA as defined the Series C Deed of Trust

      20,080

      7 The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      Information for the Company's Series D Debenture Holders

      The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of September 30, 2021, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €134 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) was 23.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA8 was 1.5. 

      The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended September 30, 2021:

       

      For the four quarter period
      ended September 30, 2021

       

      Unaudited

       

      € in thousands

      Loss for the period

      (6,907)

      Financing expenses, net

      11,782

      Taxes on income

      267

      Depreciation

      11,779

      Adjustment to revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      3,112

      Share-based payments

      47

      Adjustment to data relating to projects with a Commercial Operation
      Date during the four preceding quarters9

      6,899

      Adjusted EBITDA as defined the Series D Deed of Trust

      26,979

      8 The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      9 The adjustment is based on the results of the Talasol Project since January 27, 2021 and of the biogas plant in Gelderland since January 1, 2021. The results of the biogas plant in Gelderland were not included in the profit and loss statement of the Company for the year ended December 31, 2020.

      SOURCE Ellomay Capital Ltd.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.